List of Tables
Table 1. Global Oral Peptide Therapy Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Oral Peptide Therapy Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Oral Peptide Therapy Market Competitive Situation by Manufacturers in 2024
Table 4. Global Oral Peptide Therapy Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Oral Peptide Therapy Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Oral Peptide Therapy Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Oral Peptide Therapy Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Oral Peptide Therapy Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Oral Peptide Therapy, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Oral Peptide Therapy, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Oral Peptide Therapy, Product Type & Application
Table 12. Global Key Manufacturers of Oral Peptide Therapy, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oral Peptide Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Peptide Therapy as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oral Peptide Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Oral Peptide Therapy Sales by Region (2020-2025) & (K Units)
Table 18. Global Oral Peptide Therapy Sales Market Share by Region (2020-2025)
Table 19. Global Oral Peptide Therapy Sales by Region (2026-2031) & (K Units)
Table 20. Global Oral Peptide Therapy Sales Market Share by Region (2026-2031)
Table 21. Global Oral Peptide Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Oral Peptide Therapy Revenue Market Share by Region (2020-2025)
Table 23. Global Oral Peptide Therapy Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Oral Peptide Therapy Revenue Market Share by Region (2026-2031)
Table 25. North America Oral Peptide Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Oral Peptide Therapy Sales by Country (2020-2025) & (K Units)
Table 27. North America Oral Peptide Therapy Sales by Country (2026-2031) & (K Units)
Table 28. North America Oral Peptide Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Oral Peptide Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Oral Peptide Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Oral Peptide Therapy Sales by Country (2020-2025) & (K Units)
Table 32. Europe Oral Peptide Therapy Sales by Country (2026-2031) & (K Units)
Table 33. Europe Oral Peptide Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Oral Peptide Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Oral Peptide Therapy Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Oral Peptide Therapy Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Oral Peptide Therapy Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Oral Peptide Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Oral Peptide Therapy Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Oral Peptide Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Oral Peptide Therapy Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Oral Peptide Therapy Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Oral Peptide Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Oral Peptide Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Oral Peptide Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Oral Peptide Therapy Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Oral Peptide Therapy Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Oral Peptide Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Oral Peptide Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Oral Peptide Therapy Sales (K Units) by Type (2020-2025)
Table 51. Global Oral Peptide Therapy Sales (K Units) by Type (2026-2031)
Table 52. Global Oral Peptide Therapy Sales Market Share by Type (2020-2025)
Table 53. Global Oral Peptide Therapy Sales Market Share by Type (2026-2031)
Table 54. Global Oral Peptide Therapy Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Oral Peptide Therapy Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Oral Peptide Therapy Revenue Market Share by Type (2020-2025)
Table 57. Global Oral Peptide Therapy Revenue Market Share by Type (2026-2031)
Table 58. Global Oral Peptide Therapy Price (US$/Unit) by Type (2020-2025)
Table 59. Global Oral Peptide Therapy Price (US$/Unit) by Type (2026-2031)
Table 60. Global Oral Peptide Therapy Sales (K Units) by Application (2020-2025)
Table 61. Global Oral Peptide Therapy Sales (K Units) by Application (2026-2031)
Table 62. Global Oral Peptide Therapy Sales Market Share by Application (2020-2025)
Table 63. Global Oral Peptide Therapy Sales Market Share by Application (2026-2031)
Table 64. Global Oral Peptide Therapy Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Oral Peptide Therapy Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Oral Peptide Therapy Revenue Market Share by Application (2020-2025)
Table 67. Global Oral Peptide Therapy Revenue Market Share by Application (2026-2031)
Table 68. Global Oral Peptide Therapy Price (US$/Unit) by Application (2020-2025)
Table 69. Global Oral Peptide Therapy Price (US$/Unit) by Application (2026-2031)
Table 70. Allergan Company Information
Table 71. Allergan Description and Business Overview
Table 72. Allergan Oral Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Allergan Oral Peptide Therapy Product
Table 74. Allergan Recent Developments/Updates
Table 75. Novo Nordisk Company Information
Table 76. Novo Nordisk Description and Business Overview
Table 77. Novo Nordisk Oral Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Novo Nordisk Oral Peptide Therapy Product
Table 79. Novo Nordisk Recent Developments/Updates
Table 80. Synergy Pharmaceuticals （Salix） Company Information
Table 81. Synergy Pharmaceuticals （Salix） Description and Business Overview
Table 82. Synergy Pharmaceuticals （Salix） Oral Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Synergy Pharmaceuticals （Salix） Oral Peptide Therapy Product
Table 84. Synergy Pharmaceuticals （Salix） Recent Developments/Updates
Table 85. Novartis Company Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Oral Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Novartis Oral Peptide Therapy Product
Table 89. Novartis Recent Developments/Updates
Table 90. Chiasma Company Information
Table 91. Chiasma Description and Business Overview
Table 92. Chiasma Oral Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Chiasma Oral Peptide Therapy Product
Table 94. Chiasma Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Oral Peptide Therapy Distributors List
Table 98. Oral Peptide Therapy Customers List
Table 99. Oral Peptide Therapy Market Trends
Table 100. Oral Peptide Therapy Market Drivers
Table 101. Oral Peptide Therapy Market Challenges
Table 102. Oral Peptide Therapy Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Product Picture of Oral Peptide Therapy
Figure 2. Global Oral Peptide Therapy Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Oral Peptide Therapy Market Share by Type: 2024 & 2031
Figure 4. Linaclotide Product Picture
Figure 5. Insulin Product Picture
Figure 6. Plecanatide Product Picture
Figure 7. Cyclosporine Product Picture
Figure 8. Octreotide Product Picture
Figure 9. Global Oral Peptide Therapy Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Oral Peptide Therapy Market Share by Application: 2024 & 2031
Figure 11. Hospital
Figure 12. Retail Pharmacy
Figure 13. Global Oral Peptide Therapy Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Oral Peptide Therapy Market Size (2020-2031) & (US$ Million)
Figure 15. Global Oral Peptide Therapy Sales (2020-2031) & (K Units)
Figure 16. Global Oral Peptide Therapy Average Price (US$/Unit) & (2020-2031)
Figure 17. Oral Peptide Therapy Report Years Considered
Figure 18. Oral Peptide Therapy Sales Share by Manufacturers in 2024
Figure 19. Global Oral Peptide Therapy Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Oral Peptide Therapy Players: Market Share by Revenue in Oral Peptide Therapy in 2024
Figure 21. Oral Peptide Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Oral Peptide Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Oral Peptide Therapy Sales Market Share by Country (2020-2031)
Figure 24. North America Oral Peptide Therapy Revenue Market Share by Country (2020-2031)
Figure 25. U.S. Oral Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Oral Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Oral Peptide Therapy Sales Market Share by Country (2020-2031)
Figure 28. Europe Oral Peptide Therapy Revenue Market Share by Country (2020-2031)
Figure 29. Germany Oral Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Oral Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Oral Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Oral Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Oral Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Oral Peptide Therapy Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Oral Peptide Therapy Revenue Market Share by Region (2020-2031)
Figure 36. China Oral Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Oral Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Oral Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Oral Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Oral Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Taiwan Oral Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Oral Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Oral Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Oral Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Philippines Oral Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Latin America Oral Peptide Therapy Sales Market Share by Country (2020-2031)
Figure 47. Latin America Oral Peptide Therapy Revenue Market Share by Country (2020-2031)
Figure 48. Mexico Oral Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Brazil Oral Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Argentina Oral Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Middle East and Africa Oral Peptide Therapy Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Oral Peptide Therapy Revenue Market Share by Country (2020-2031)
Figure 53. Turkey Oral Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Oral Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. U.A.E Oral Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Global Sales Market Share of Oral Peptide Therapy by Type (2020-2031)
Figure 57. Global Revenue Market Share of Oral Peptide Therapy by Type (2020-2031)
Figure 58. Global Oral Peptide Therapy Price (US$/Unit) by Type (2020-2031)
Figure 59. Global Sales Market Share of Oral Peptide Therapy by Application (2020-2031)
Figure 60. Global Revenue Market Share of Oral Peptide Therapy by Application (2020-2031)
Figure 61. Global Oral Peptide Therapy Price (US$/Unit) by Application (2020-2031)
Figure 62. Oral Peptide Therapy Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
